We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Post-Grant Review Of Multiple Sclerosis Treatment Patent Sought

(July 14, 2016, 11:49 AM EDT) -- ALEXANDRIA, Va. — A claimed method of treating multiple sclerosis (MS) with the injection of 40 milligrams of glatiramer acetate (GA) thrice weekly should not have received federal patent protection, Amneal...
To view the full article, register now.